Ameliorated Chemotherapeutic Potential of Diverse Dose Flouropyrimidine Therapy By Etodolac via NF-ΚB Pathway, PPAR-γ Expression and COX-II Inhibition in DMH Induced Colon Cancer Rats

By  

Clinical Cancer Drugs, Vol. 3, Iss. 2, 2016-10 ,pp. : 109-120

Bentham Science Publishers

Access to resources Recommend Favorite

Scutellarin protects against lipopolysaccharide-induced acute lung injury via inhibition of NF-B activation in mice

By Tan Zheng-Huai   Yu Ling-Hong   Wei Huai-Ling   Liu Geng-Tao  

Journal of Asian Natural Products Research, Vol. 12, Iss. 3, 2010-03 ,pp. : 175-184

Taylor & Francis Ltd

Access to resources Recommend Favorite

The NF-kB Pathway as a Potential Target for Autoimmune Disease Therapy

By  

Current Pharmaceutical Design, Vol. 10, Iss. 23, 2004-09 ,pp. : 2827-2837

Bentham Science Publishers

Access to resources Recommend Favorite

PPAR and PPAR activators inhibit cytokine-induced nuclear translocation of NF- B and expression of VCAM-1 in EAhy926 endothelial cells

By Rival Y.   Beneteau N.   Taillandier T.   Pezet M.   Dupont-Passelaigue E.   Patoiseau J.-F.   Junquero D.   Colpaert F.C.   Delhon A.  

European Journal of Pharmacology, Vol. 435, Iss. 2, 2002-01 ,pp. : 143-151

Elsevier

Access to resources Recommend Favorite

Pioglitazone, a PPAR-γ ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-κB-cytokine cascade

By  

Redox Report, Vol. 17, Iss. 1, 2012-01 ,pp. : 47-47

Maney Publishing

Access to resources Recommend Favorite